×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MYNZ – mainz biomed n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MYNZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:01 am
mynz
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
High
Report
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
12/16
05:00 pm
mynz
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
Medium
Report
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
12/12
08:00 pm
mynz
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
Medium
Report
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
11/29
08:45 am
mynz
Mainz Biomed Announces Stock Split
High
Report
Mainz Biomed Announces Stock Split
11/25
08:02 am
mynz
Mainz Biomed (NASDAQ: MYNZ) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
Medium
Report
Mainz Biomed (NASDAQ: MYNZ) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
11/12
09:00 am
mynz
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
High
Report
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
10/21
02:11 pm
mynz
Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M [Seeking Alpha]
Low
Report
Mainz Biomed B.V. GAAP EPS of -$0.49, revenue of $520.77M [Seeking Alpha]
10/21
08:01 am
mynz
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Medium
Report
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/16
05:29 pm
mynz
Form 6-K MAINZ BIOMED N.V. For: Dec 16
Medium
Report
Form 6-K MAINZ BIOMED N.V. For: Dec 16
12/13
08:00 am
mynz
Form 6-K MAINZ BIOMED N.V. For: Dec 13
Medium
Report
Form 6-K MAINZ BIOMED N.V. For: Dec 13
12/13
06:03 am
mynz
Form EFFECT MAINZ BIOMED N.V.
Medium
Report
Form EFFECT MAINZ BIOMED N.V.
11/29
08:46 am
mynz
Form 6-K MAINZ BIOMED N.V. For: Nov 29
Medium
Report
Form 6-K MAINZ BIOMED N.V. For: Nov 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: